Literature DB >> 26882253

A PTENtial cause for the selectivity of oncolytic viruses?

Brian R Champion1, Kerry Fisher2, Len Seymour3.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26882253     DOI: 10.1038/ni.3394

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

Authors:  Laura Poliseno; Leonardo Salmena; Luisa Riccardi; Alessandro Fornari; Min Sup Song; Robin M Hobbs; Paolo Sportoletti; Shorheh Varmeh; Ainara Egia; Giuseppe Fedele; Lucia Rameh; Massimo Loda; Pier Paolo Pandolfi
Journal:  Sci Signal       Date:  2010-04-13       Impact factor: 8.192

2.  The tumor suppressor PTEN has a critical role in antiviral innate immunity.

Authors:  Shun Li; Mingzhu Zhu; Ruangang Pan; Ting Fang; Yuan-Yuan Cao; Shuliang Chen; Xiaolu Zhao; Cao-Qi Lei; Lin Guo; Yu Chen; Chun-Mei Li; Eija Jokitalo; Yuxin Yin; Hong-Bing Shu; Deyin Guo
Journal:  Nat Immunol       Date:  2015-12-21       Impact factor: 25.606

Review 3.  Mutations of the human PTEN gene.

Authors:  D Bonneau; M Longy
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Promoter methylation of the PTEN gene is a common molecular change in breast cancer.

Authors:  Jose M García; Javier Silva; Cristina Peña; Vanesa Garcia; Rufo Rodríguez; Miguel A Cruz; Blanca Cantos; Mariano Provencio; Pilar España; Felix Bonilla
Journal:  Genes Chromosomes Cancer       Date:  2004-10       Impact factor: 5.006

5.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

Review 6.  The role of differential expression of human interferon--a genes in antiviral immunity.

Authors:  Pierre Génin; Alexandra Vaccaro; Ahmet Civas
Journal:  Cytokine Growth Factor Rev       Date:  2009-08-03       Impact factor: 7.638

7.  Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling.

Authors:  Ping Zhang; Charles E Samuel
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

8.  Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.

Authors:  Siqi Liu; Xin Cai; Jiaxi Wu; Qian Cong; Xiang Chen; Tuo Li; Fenghe Du; Junyao Ren; You-Tong Wu; Nick V Grishin; Zhijian J Chen
Journal:  Science       Date:  2015-01-29       Impact factor: 47.728

9.  MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.

Authors:  E Nagy; K B Gajjar; I I Patel; S Taylor; P L Martin-Hirsch; H F Stringfellow; F L Martin; D H Phillips
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

10.  Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.

Authors:  Katie Twigger; Victoria Roulstone; Joan Kyula; Eleni M Karapanagiotou; Konstantinos N Syrigos; Richard Morgan; Christine White; Shreerang Bhide; Gerard Nuovo; Matt Coffey; Brad Thompson; Adel Jebar; Fiona Errington; Alan A Melcher; Richard G Vile; Hardev S Pandha; Kevin J Harrington
Journal:  BMC Cancer       Date:  2012-08-24       Impact factor: 4.430

View more
  7 in total

Review 1.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

Review 2.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

3.  Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.

Authors:  Sébastien A Felt; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2017-12       Impact factor: 3.891

Review 4.  Clinical implications of PTEN loss in prostate cancer.

Authors:  Tamara Jamaspishvili; David M Berman; Ashley E Ross; Howard I Scher; Angelo M De Marzo; Jeremy A Squire; Tamara L Lotan
Journal:  Nat Rev Urol       Date:  2018-02-20       Impact factor: 14.432

Review 5.  Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.

Authors:  Raquel Yokoda; Bolni M Nagalo; Brent Vernon; Rahmi Oklu; Hassan Albadawi; Thomas T DeLeon; Yumei Zhou; Jan B Egan; Dan G Duda; Mitesh J Borad
Journal:  Oncolytic Virother       Date:  2017-11-08

Review 6.  Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?

Authors:  Vildan B Cetintas; Nizar N Batada
Journal:  J Transl Med       Date:  2020-01-30       Impact factor: 5.531

7.  Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling.

Authors:  Gráinne McEntee; Joan N Kyula; David Mansfield; Henry Smith; Michelle Wilkinson; Claire Gregory; Victoria Roulstone; Matt Coffey; Kevin J Harrington
Journal:  Oncotarget       Date:  2016-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.